Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma

scientific article published on January 2001

Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S002640100273
P932PMC publication ID3620808
P698PubMed publication ID11794258
P5875ResearchGate publication ID11564995

P2093author name stringS M Kumta
L T Chow
P C Leung
K M Lee
J Griffith
Q S Zhu
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectdoxorubicinQ18936
immunohistochemistryQ899285
P304page(s)279-282
P577publication date2001-01-01
P1433published inInternational OrthopaedicsQ15767032
P1476titleClinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma
P478volume25

Reverse relations

cites work (P2860)
Q80510573Biology and therapy of malignant solid tumors in childhood
Q36532115Chemotherapy resistance in osteosarcoma: current challenges and future directions.
Q39502697P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma.
Q43984262The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis

Search more.